-
3X (DYKDDDDK) Peptide for ERES Assays
2026-09-08
The 3X (DYKDDDDK) Peptide provides a compact, hydrophilic epitope system for interpreting ER exit-site organization. This article connects FLAG-based detection and purification with the cooperative Tango1–Sec16–Sec12 model, emphasizing assay design, controls, and metal-sensitive workflows.
-
JZL184 Workflows for MAGL and Pain Research
2026-09-08
JZL184 provides a controlled way to inhibit MAGL, elevate 2-AG, and test CB1-linked synaptic, pain, and affective mechanisms. This workflow-focused guide connects biochemical target engagement with electrophysiology, LC-MS/MS, and behavioral validation while emphasizing vehicle control and interpretation limits.
-
PID1, Oxysterols, and Macrophage Fate
2026-09-07
The reference study identifies PID1 as an immunometabolic brake in tumor-associated macrophages: its loss increases LDL uptake, cholesterol accumulation, and ROS-dependent production of 5α,6α-epoxycholesterol and 7β-hydroxycholesterol. These oxysterols inhibit mTOR–STAT6–ARG1 signaling, reprogram macrophages toward antitumor activity, and improve CD8+ T cell surveillance, including in combination with 5-fluorouracil.
-
BV6 and the Translational Logic of IAP Antagonism
2026-09-07
BV6 is more than a cytotoxicity reagent: it is a mechanistic probe for testing whether IAP-dependent survival limits apoptosis, radiotherapy response, chemotherapy response, or immune-cell killing. This perspective connects BV6 biology with disciplined assay design, the distinction between apoptosis and necroptosis, and translational decision-making across cancer and endometriosis models.
-
12-O-tetradecanoyl phorbol-13-acetate Workflows
2026-09-05
Build reproducible PKC and ERK/MAPK experiments with TPA using time-resolved stimulation, orthogonal phenotype readouts, and disciplined stock handling. The workflow connects kinase assays, cancer biology, and carefully bounded immune-signaling applications without treating pathway activation as a substitute for mechanistic validation.
-
U3 snoRNA–DDX21 Control of Mitotic Perichromosomal Regions
2026-09-04
This 2024 study shows that U3 snoRNA is an active regulator of mitotic progression rather than a passive chromosome passenger. By defining a reciprocal relationship between U3 snoRNA and the RNA helicase DDX21, the work connects perichromosomal-region organization, RNA mobility, and condensate properties with mitotic control.
-
Graphene FIR Triggers Apoptosis in Melanoma
2026-09-04
A 2025 BMC Cancer study shows that graphene-mediated far-infrared radiation suppresses B16F10 melanoma growth through coordinated apoptosis, G0/G1 arrest, and altered hypoxia-related signaling. Pharmacological rescue with Z-DEVD-FMK and Z-LEHD-FMK supports contributions from caspase-3 and caspase-9 signaling, while the combined in vitro, transcriptomic, and syngeneic-mouse design provides a useful framework for mechanism-focused melanoma research.
-
Spirocyclic POM Analogues Target MmpL3 in TB
2026-09-03
This 2024 study developed spirocyclic phenyl oxazole methyl analogues and identified compound 5c as a potent inhibitor of Mycobacterium tuberculosis, including drug-resistant clinical isolates. Phenotypic screening, spontaneous mutant generation, and docking linked activity to the essential transporter MmpL3, providing a useful framework for early anti-tubercular lead discovery.
-
0.4% Trypan Blue Solution: Practical QC Guide
2026-09-03
0.4% Trypan Blue Solution supports rapid cell viability measurement, live/dead cell discrimination, and cell counting by staining dead or membrane-damaged cells blue. It is intended for controlled research workflows such as cell culture and cytotoxicity assays, but not for diagnostic, clinical, or medical use.
-
CpAdhE as an Antiparasitic Drug Target
2026-09-02
A 2024 study characterized the bacterial-type bifunctional aldehyde/alcohol dehydrogenase CpAdhE in Cryptosporidium parvum and connected enzyme inhibition with antiparasitic activity in cell culture. Screening identified antifungal imidazoles as lower-micromolar inhibitors, providing a target-to-cell validation framework while leaving selectivity, target engagement, and in vivo efficacy for future investigation.
-
CUDC-907 Dual PI3K/HDAC Assay Guide
2026-09-02
CUDC-907 (SKU A4097) provides a research starting point for simultaneous PI3K and HDAC pathway perturbation in cancer cell assays. It should be used in controlled in vitro workflows with solvent, exposure, and assay-specific controls, not for diagnostic, therapeutic, or clinical applications.
-
ROS-Degradable LNPs for Tumor-Selective mRNA Delivery
2026-09-01
The reference study developed a combinatorial library of thioketal-containing, ROS-degradable lipid nanoparticles and identified BAmP-TK-12 as a preferential mRNA delivery vehicle for tumor cells. Its delivery of DUF5-encoding mRNA depleted mutant RAS and produced stronger antitumor activity than a small-molecule RAS inhibitor, while also highlighting the importance of lipid pKa and intracellular degradation.
-
Polymyxin B Sulfate: Mechanism and Research Uses
2026-09-01
Polymyxin B sulfate is a cationic polypeptide antibiotic used in Gram-negative bacterial infection research. Its membrane-disrupting activity, immunomodulatory observations, and defined handling parameters support studies of multidrug resistance, dendritic cell maturation assays, and sepsis and bacteremia models.
-
Alternariol (AOH) Workflow for Hepatotoxicity
2026-08-31
Alternariol (AOH) is a defined mycotoxin tool for connecting exposure, CYP1A metabolism, apoptosis, cytoskeletal remodeling, and hepatic stellate-cell activation. This workflow translates recent LX-2 findings into practical dosing, controls, readouts, and troubleshooting decisions for reproducible mycotoxin research.
-
Carbapenemase Transmission in Enterobacter cloacae
2026-08-31
Chen et al. characterized carbapenemase-encoding genes in 54 carbapenem-resistant Enterobacter cloacae isolates from eight Guangdong teaching hospitals, combining gene localization, conjugation, mobile-element analysis, and strain genotyping. The study shows that blaNDM-1 was common, frequently plasmid-associated, and readily transferable, linking multidrug resistance with both horizontal dissemination and genetically related hospital isolates.